A total of 7,3MSEK of investment is secured as convertible loan through investment from both existing investors and 4 new angel/private investors. The capital will
The patent application on the basic concept of PexyEazy® have been accepted in Australia, India and EU. The patent is now valid in USA, Japan,
PexyEazy® was in the spotlight at the ASCRS conference in Baltimore 1-4 of June under the slogan “Mucopexy made easy. This event is one of
As part of the ongoing clinical investigation, the SCI-Pex study, was the first PexyEaxy® procedure done on an awake patient, without general anesthesia. The procedure
The patent application on the basic concept of PexyEazy® is accepted in USA, Japan, Singapore, Russia, South Africa, Israel and China. The international patent applications
First PexyEazy® procedure on human, as the first patient participated in the SCI-Pex study, a safety and feasibility study on PexyEazy®. A total of 35
Additional investment of 3,17MSEK is secured from existing investors to finance the upcoming clinical investigtion, the SCI-Pex study.
Developeration AB was awarded “Seal of Excellence” by the European Commission as part of the application for Horizon EIC 2022 Accelerator grant. Our application was
Developeration AB was awarded by the Scandinavian Business Awards as the “Most Innovative Operation Research & Development Company – Sweden”. https://www.eubusinessnews.com/winners/developeration-ab/
ALMI Invest, STOAF, Rentability AB, Adiuvero AB and GAEU Venture AB invest I Developeration AB’s second investment round, in total 11,5 MSEK.
Developeration has been acknowledged as the “Best Medical Devices Developer – Scandinavia” by GHP, Global Health and Pharmacy, a global information sharing platform. https://www.ghp-news.com/winners-list/?award=11481-2021
Developeration AB is accepted to the EIT Health Investor Network as a GOLD Company.
Developeration has been acknowledged as the “Most innovative medical devices developer – Scandinavia” by GHP, Global Health and Pharmacy, a global information sharing platform. https://www.ghp-news.com/winners/developeration-ab/
2020-09-15 ALMI Invest and STOAF, invest in Developeration AB, in total 4,4MSEK. https://stoaf.se/2020/09/15/stoaf-invests-in-developerations-innovative-surgical-device/
Developeration AB receives 2,56MSEK in funding for product development and clinical investigations from Sthlm Life Scale-Up Program from Region Stockholm, KI Innovations AB and Tillväxtverket.
Developeration’s novel device PexyEazy for the surgical treatment of haemorrhoids has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement
Developeration AB become a member of the Karolinska Institutet Innovations incubator programme, DRIVE. https://www.lifesciencesweden.se/article/view/599332/ki_innovations_valjer_ut_bolag http://www.mynewsdesk.com/se/karolinska-institutet-innovations-ab/pressreleases/nu-erbjuder-vi-starkare-stoed-till-innovativa-bolag-inom-life-science-2492287
Developeration AB receives funding from Novo nordisk fonden, Exploratory Pre-seed.
Developeration AB receives funding from EIT Health, Proof of Concept.
Developeration AB receives funding from Vinnova, “Innovativa Startups, fas 1”, for further development of PexyEazy, a new operation method for treatment of haemorrhoids. https://www.vinnova.se/p/pexyeazy—en-ny-operationsmetod-for-behandling-av-hemorrojder/
Developeration AB participate in the program for entrepreneur, STING (Stockholm Innovation & Growth) Test Drive Health. http://www.mynewsdesk.com/se/stockholm_innovation___growth__sting/pressreleases/13-innovativa-haelsostartups-utvalda-till-sting-test-drive-1745877
Developeration AB receives funding from Vinnova for development of a new operation methods for treatment of haemorrhoids. http://www.vinnova.se/sv/Resultat/Projekt/Effekta/2009-02172/Utveckling-av-nytt-operationsinstrument-for-behandling-av-hemorrojder/